Raptor’s mission is to develop and commercialize life-altering therapeutics that treat debilitating and often fatal diseases. Raptor is a NASDAQ-listed biopharmaceutical company with a product pipeline that may advance therapeutic options for five different indications and includes potential for product launch within the next several months. Raptor’s management team consists of repeat entrepreneurs with the … Continue reading Raptor Pharmaceuticals Corp.
DexCom, Inc., headquartered in San Diego, California, is developing and marketing continuous glucose monitoring systems for ambulatory use by patients and by healthcare providers in the hospital.
What we do is not rocket surgery. That’s your job. But we do love science and have a flair for communicating it. For more than a decade, we’ve helped science-based companies speak with their markets. It’s a journey that’s taken us from the lab to the boardroom and all points in between. Along the way, … Continue reading CG Life
Shire Regenerative Medicine provides regenerative medicine solutions for people with life-altering conditions. They aspire to harness the power of regenerative medicine to address society’s unmet medical needs, and are focused on developing and delivering solutions that support the body’s natural healing process.
Established in 1996, Evaluate Ltd. is the leader in high quality life science sector analysis. EvaluatePharma delivers exclusive consensus forecasts and trusted commercial insight into biotech and pharmaceutical performance. EvaluateMedTech sets a new standard in integrated analysis and consensus forecasts of the global medical device and diagnostic industry. EvaluateClinical Trials delivers unique intelligence to efficiently … Continue reading EvaluatePharma USA, Inc.
BioMarin Pharmaceutical Inc. (Nasdaq and SWX: BMRN) develops and commercializes innovative biopharmaceuticals for serious diseases and medical conditions. The company’s product portfolio is comprised of two approved products and multiple investigational product candidates. Orapred® (prednisolone sodium phosphate oral solution) is approved in the United States for exacerbations of asthma and other inflammatory conditions, and Aldurazyme® … Continue reading BioMarin Pharmaceutical, Inc.